df277947-6248-4251-8bc3-3ed7e4dbaa00Q1 — 1st Quarter - ReportTHE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
Support policies and appropriations relevant to find and deliver cures for breast cancer.
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
POS — PostalH.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research.
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
BUD — Budget/AppropriationsH.R.5304/S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; a bill to provide for FY2026 appropriations to the Departments of Labor, Health and Human Services, and Education; and related agencies. H.R.4016/S.2572 - Department of Defense Appropriations Act, 2026; a bill to provide for FY2026 appropriations to the Department of Defense (DOD) for military activities. H.R.7148 - Consolidated Appropriations Act, 2026; a bill to provide appropriations to several federal departments and agencies, including the Departments of Defense and Labor, Health and Human Services, and Education, for the remainder of FY2026 and provides continuing FY2026 appropriations for the Department of Homeland Security (DHS) through February 13, 2026. FY26 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding workforce and related cancer services FY27 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding workforce and related cancer services and report language related to the implementation of the Medicare Prescription Payment Plan
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
INS — InsuranceH.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance H.R.5813 - Womens Health and Cancer Rights Modernization Act of 2025; a bill to amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage of certain items and services relating to breast or chest wall reconstruction furnished in connection with breast cancer treatment. Comments related to a Ways and Means Full Committee Hearing with Health Insurance CEOs Comments related to an Energy and Commerce Health Subcommittee Hearing on Lowering Health Care Costs for All Americans: An Examination of Health Insurance Affordability Implementation of the Affordable Care Act and policies related to the extension of Advanced Enhanced Premium Tax Credits Comments related to a Ways and Means Committee Hearing: Lowering Health Care Costs for All Americans Comments and engagement related to the implementation of the Affordable Care Act and H.R.1, the Big Beautiful Bill Act and relevant changes to the ACA Marketplace Comments related to Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/MedicaidH.R.842/S.339 - Medicare Multi-Cancer Early Detection Screening Coverage Act; a bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act; a bill to amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes Comments related to Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) Comments related to CMS Proposed Rule on Global Benchmark for Efficient Drug Pricing (GLOBE) Model (CMS-5545-P) Comments related to CMS Proposed Rule on Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model (CMS-5546-P) Comments related to CMS public engagement on the Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2028 and Manufacturer Effectuation of the Maximum Fair Price in 2026, 2027, and 2028
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE
HCR — Health IssuesH.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill To reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009. H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research. Comments related to Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1125-N Comments in response to HHS Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care (RIN 0955-AA13)
Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.